In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
August 15th, 2007 | 16 | Yes |
Popular Name: Milrinone Milrinone
Find On: PubMed — Wikipedia — Google
CAS Numbers: 100286-97-3 , 78415-72-2 , [100286-97-3] , [78415-72-2]
(3,4'-BIPYRIDINE)-5-CARBONITRILE, 1,6-DIHYDRO-2-METHYL-6-OXO-
(3,4'-Bipyridine)-5-carbonitrile, 6-dihydro-2-methyl-6-oxo-
1,2-Dihydro-6-methyl-2-oxo-5-pyridin-4-ylnicotinonitrile
1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile
1,6-Dihydro-2-methyl-6-oxo-(3,4&prime
1,6-Dihydro-2-methyl-6-oxo-(3,4'-bipyridine)-5-carbonitrile
1,6-Dihydro-2-methyl-6-oxo-3,4-bipyridine-5-carbonitrile
1,6-Dihydro-2-methyl-6-oxo-[3,4'-bipyridine]-5-carbonitrile
100286-97-3; C13595; Milrinone lactate
100286-97-3; D02085; Milrinone lactate; Primacor (TN)
2-Methyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile
2-Methyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile (Milrinone)
3-Cyano-6-methyl-5-(4-pyridyl)-2-pyridone
6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile
6-Methyl-5-(4-pyridyl)-2-pyridone-3-carbonitrile
78415-72-2; D00417; Milrila (TN); Milrinone (JAN/USP/INN)
CPD000058475; MILRINONE; 78415-72-2
CPD000058475; MILRINONE; SAM001246611
MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 0.94 | 4.19 | -16.01 | 1 | 4 | 0 | 70 | 211.224 | 1 | ↓ |
Hi High (pH 8-9.5) | 1.40 | 2.16 | -43.19 | 0 | 4 | -1 | 73 | 210.216 | 1 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 2.09e-01 g/l | DrugBank-approved |
Purity | 97% | Fluorochem |
Mp [°C] | >280 | Acros Organics |
Target | ATPase | Selleck Chemicals |
Therapy | cardiotonic | SMDC Iconix |
Patent Database Links | EP1579862; EP1839675; US2006040929; US2007191371; US2007196856; US2007203155; US2007244130; US2007259890; US2008292608; WO2005113506; WO2005113519; WO2005116000; WO2005116016; WO2006084176; WO2007087448; WO2007089557; WO2007089667; WO2007128349; WO2008138 | ChEBI |
H phrase | H301: Toxic if swallowed | Acros Organics |
H phrase | H301: Toxic if swallowed; H330: Fatal if inhaled; H311: Toxic in contact with skin | Acros Organics |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP06575m | NIH Clinical Collection via PubChem |
P phrase | P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician | Acros Organics |
P phrase | P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician; P280: Wear protective gloves/protective clothing/eye protection/face protection; P312: Call a POISON CENTER or doctor/physician if you feel unwell; P302 + P350: IF ON SKIN: G | Acros Organics |
UniProt Database Links | PDE7B_HUMAN; PDE7B_MOUSE; PDE8B_HUMAN | ChEBI |
R phrase | R23/24/25: Toxic by inhalation, in contact with skin and if swallowed. | Acros Organics |
S phrase | S36/37/39: Wear suitable protective clothing, gloves and eye/face protection. | Acros Organics |
S phrase | S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.; S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). | Acros Organics |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP06575m | NIH Clinical Collection via PubChem |
Hazard | T: Toxic | Acros Organics |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
E1BN64-1-E | Phosphodiesterase 3B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1000 | 0.53 | Binding ≤ 10μM |
O77823-1-E | Phosphodiesterase 4A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6000 | 0.46 | Binding ≤ 10μM |
PDE1A-1-E | Phosphodiesterase 1A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5500 | 0.46 | Binding ≤ 10μM |
PDE3A-2-E | Phosphodiesterase 3A (cluster #2 Of 2), Eukaryotic | Eukaryotes | 930 | 0.53 | Binding ≤ 10μM |
PDE3B-2-E | Phosphodiesterase 3B (cluster #2 Of 2), Eukaryotic | Eukaryotes | 930 | 0.53 | Binding ≤ 10μM |
PDE4A-3-E | Phosphodiesterase 4A (cluster #3 Of 3), Eukaryotic | Eukaryotes | 6000 | 0.46 | Binding ≤ 10μM |
PDE4B-2-E | Phosphodiesterase 4B (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6000 | 0.46 | Binding ≤ 10μM |
PDE4C-2-E | Phosphodiesterase 4C (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6000 | 0.46 | Binding ≤ 10μM |
PDE4D-2-E | Phosphodiesterase 4D (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6000 | 0.46 | Binding ≤ 10μM |
PDE5A-2-E | Phosphodiesterase 5A (cluster #2 Of 2), Eukaryotic | Eukaryotes | 5000 | 0.46 | Binding ≤ 10μM |
Q864F1-1-E | Phosphodiesterase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 740 | 0.54 | Binding ≤ 10μM |
Q9XSW7-1-E | Phosphodiesterase 3A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 843 | 0.53 | Binding ≤ 10μM |
PGH1-1-E | Cyclooxygenase-1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4700 | 0.47 | Functional ≤ 10μM |
Z102213-1-O | Blood (cluster #1 Of 2), Other | Other | 4700 | 0.47 | Functional ≤ 10μM |
Z102306-1-O | Aorta (cluster #1 Of 6), Other | Other | 122 | 0.60 | Functional ≤ 10μM |
Z50512-5-O | Cavia Porcellus (cluster #5 Of 7), Other | Other | 4700 | 0.47 | Functional ≤ 10μM |
Z50587-1-O | Homo Sapiens (cluster #1 Of 9), Other | Other | 9000 | 0.44 | Functional ≤ 10μM |
Z50588-6-O | Canis Familiaris (cluster #6 Of 7), Other | Other | 700 | 0.54 | Functional ≤ 10μM |
Z50589-1-O | Felis Catus (cluster #1 Of 2), Other | Other | 7700 | 0.45 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Q9XSW7_PIG | Q9XSW7 | Phosphodiesterase 3A, Pig | 843 | 0.53 | Binding ≤ 1μM |
PDE3A_RAT | Q62865 | Phosphodiesterase 3A, Rat | 740 | 0.54 | Binding ≤ 1μM |
PDE3A_HUMAN | Q14432 | Phosphodiesterase 3A, Human | 150 | 0.60 | Binding ≤ 1μM |
PDE3B_RAT | Q63085 | Phosphodiesterase 3B, Rat | 740 | 0.54 | Binding ≤ 1μM |
PDE3B_HUMAN | Q13370 | Phosphodiesterase 3B, Human | 150 | 0.60 | Binding ≤ 1μM |
E1BN64_BOVIN | E1BN64 | Phosphodiesterase 3B, Bovin | 1000 | 0.53 | Binding ≤ 1μM |
Q864F1_PIG | Q864F1 | Phosphodiesterase 5, Pig | 740 | 0.54 | Binding ≤ 1μM |
PDE1A_BOVIN | P14100 | Phosphodiesterase 1A, Bovin | 5500 | 0.46 | Binding ≤ 10μM |
PDE3A_RAT | Q62865 | Phosphodiesterase 3A, Rat | 740 | 0.54 | Binding ≤ 10μM |
PDE3A_HUMAN | Q14432 | Phosphodiesterase 3A, Human | 1100 | 0.52 | Binding ≤ 10μM |
Q9XSW7_PIG | Q9XSW7 | Phosphodiesterase 3A, Pig | 843 | 0.53 | Binding ≤ 10μM |
PDE3B_RAT | Q63085 | Phosphodiesterase 3B, Rat | 740 | 0.54 | Binding ≤ 10μM |
E1BN64_BOVIN | E1BN64 | Phosphodiesterase 3B, Bovin | 1000 | 0.53 | Binding ≤ 10μM |
PDE3B_HUMAN | Q13370 | Phosphodiesterase 3B, Human | 1100 | 0.52 | Binding ≤ 10μM |
PDE4A_HUMAN | P27815 | Phosphodiesterase 4A, Human | 10000 | 0.44 | Binding ≤ 10μM |
O77823_PIG | O77823 | Phosphodiesterase 4A, Pig | 10000 | 0.44 | Binding ≤ 10μM |
PDE4B_HUMAN | Q07343 | Phosphodiesterase 4B, Human | 10000 | 0.44 | Binding ≤ 10μM |
PDE4C_HUMAN | Q08493 | Phosphodiesterase 4C, Human | 10000 | 0.44 | Binding ≤ 10μM |
PDE4D_HUMAN | Q08499 | Phosphodiesterase 4D, Human | 10000 | 0.44 | Binding ≤ 10μM |
Q864F1_PIG | Q864F1 | Phosphodiesterase 5, Pig | 740 | 0.54 | Binding ≤ 10μM |
PDE5A_BOVIN | Q28156 | Phosphodiesterase 5A, Bovin | 5000 | 0.46 | Binding ≤ 10μM |
Z102306 | Z102306 | Aorta | 122 | 0.60 | Functional ≤ 10μM |
Z102213 | Z102213 | Blood | 4700 | 0.47 | Functional ≤ 10μM |
Z50588 | Z50588 | Canis Familiaris | 1600 | 0.51 | Functional ≤ 10μM |
Z50512 | Z50512 | Cavia Porcellus | 4700 | 0.47 | Functional ≤ 10μM |
PGH1_HUMAN | P23219 | Cyclooxygenase-1, Human | 4700 | 0.47 | Functional ≤ 10μM |
Z50589 | Z50589 | Felis Catus | 6500 | 0.45 | Functional ≤ 10μM |
Z50587 | Z50587 | Homo Sapiens | 100 | 0.61 | Functional ≤ 10μM |
Description | Species |
---|---|
Cam-PDE 1 activation | |
cGMP effects | |
COX reactions | |
DARPP-32 events | |
G alpha (s) signalling events | |
PDE3B signalling | |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) |